Regulatory Changes Cut Licensing Burden for Device Makers Using Third‑Party Sterilizers
The recent revision of Rule 44 removes the requirement for a distinct "loan licence" when a medical device producer outsources sterilisation to a facility holding a valid licence under the 2017 rules. By eliminating duplicated authorisations, manufacturers can accelerate time‑to‑market, lower administrative overheads, and focus on product development. Industry bodies welcomed the move as a concrete step toward an "ease of doing business" environment in the Indian medical device sector.